Researchers have been excited about Retatrutide , a novel dual agonist showing promising outcomes in initial trials for size loss . It functions by targeting both pathways : GLP-1 and GIP, these, when https://lewiswami217957.blogzag.com/84154182/this-new-possibility-for-weight-loss